مجله دانشگاه علوم پزشکی سبزوار

شماره جاری

بر اساس شماره‌های نشریه

بر اساس نویسندگان

بر اساس موضوعات

نمایه نویسندگان

نمایه کلیدواژه ها

درباره نشریه

اهداف و چشم انداز

اعضای هیات تحریریه

اصول اخلاقی انتشار مقاله

بانک ها و نمایه نامه ها

پیوندهای مفید

فرایند پذیرش مقالات

اخبار و اعلانات

فرم های ضروری نشریه

راهنمای تنظیم مقاله

تأثیرات گوارشی و کبدی شاهتره در طب سنتی ایران و مطالعات پزشکی نوین: یک مطالعه مروری

نوع مقاله : مروری

نویسندگان

1 دانشجوی دکتری عمومی داروسازی، کمیته تحقیقات دانشجویی، دانشکده داروسازی، دانشگاه علوم پزشکی مشهد، مشهد، ایران

2 استادیار طب ایرانی، گروه طب ایرانی، دانشکده طب ایرانی و مکمل، دانشگاه علوم پزشکی مشهد، مشهد، ایران

چکیده

زمینه و هدف: در طب ایرانی گیاه شاهتره در درمان بسیاری از بیماری‌ها مانند مشکلات گوارشی کاربرد داشته است. از طرفی در میان مطالعاتی که بر روی گیاهان جنس شاهتره انجام شده است، تأثیرات گوارشی و کبدی مورد توجه می‌باشد. هدف این مطالعه، مرور و بررسی تطبیقی- مقایسه‌ای تأثیرات درمانی شاهتره در طب ایرانی و مطالعات نوین پزشکی می‌باشد.
مواد و روش‌ها: کاربردهای گیاه شاهتره از کتب مرجع طب ایرانی از جمله: قانون در طب، الحاوی، مخزن الادویه، قرابادین کبیر، تحفة المومنین و ریاض الدویه به‌صورت جستجوی دستی استخراج، بررسی و دسته‌بندی شد، مقالات مرتبط در پایگاه‌های داده PubMed، Scopus ، SID وGoogle scholar جستجو گردید. در نهایت کاربردهای گیاه در طب رایج و طب ایرانی به‌صورت تطبیقی بررسی شد.
یافته‌ها: شاهتره در طب ایرانی به‌عنوان یک تقویت‌کننده معده وکبد و بازکننده انسدادهای کبدی و طحالی کاربرد داشته است. از دیگر خواص آن می‌توان به اثرات تصفیه‌کنندگی خون، ملین، اشتهاآور و پاکسازی‌کننده روده‌ها اشاره کرد. امروزه در مطالعات پایه و بالینی صورت‌گرفته بر روی گیاهان جنس شاهتره، تأثیرات هپاتوپروتکتیو و کاهنده سطوح آنزیم‌های کبدی، ضدالتهاب در ناهنجاری‌های کبدی، ضداسهال، کاهنده فاکتورهای التهابی در مشکلات گوارشی و بهبوددهنده علایم سندرم روده تحریک‌پذیر به اثبات رسیده است.
نتیجه‌گیری: براساس منابع طب ایرانی و طب مدرن شاهتره می‌تواند در برخی مشکلات گوارشی و کبدی دارای پتانسیل‌های درمانی باشد.

کلیدواژه‌ها

موضوعات

عنوان مقاله [English]

Gastrointestinal and Hepatic Effects of Fumaria Species in Traditional Persian Medicine and Modern Medical Studies: A Narrative Review

نویسندگان [English]

  • Fatemeh Kiumarsi 1
  • Ali Reza Derakhshan 2

1 Pharmacy Student, Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran

2 Assistant Professor, Department of Persian Medicine, School of Persian and Complementary Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

چکیده [English]

Introduction: In Persian medicine, fumitory has been used in the treatment of many diseases, especially gastrointestinal disorders. On the other hand, among the studies that have been done on the plants of Fumaria species, the gastrointestinal and hepatic effects have been considered by researchers. The purpose of this study is to review the comparative therapeutic effects of fumitory in Persian medicine and modern medical studies.
Materials and Methods: First, the uses of fumitory were extracted, studied and categorized from the reference books of Persian medicine, including: Qanoon, Al-Havi, Makhzan al-Adviyah, Qarabadin Kabir, Tahfa al-Momenin, and Riyaz al-Adviyah. Then, the related articles were searched in PubMed, Scopus, Cochrane, Google scholar, Magiran and SID databases. Finally, a comparative study of the applications of this plant in conventional medicine and Persian medicine was performed.
Results: This plant has been used in Persian medicine as a gastric and hepatic tonic and an opener of obstructions of the liver and spleen. Other functions include blood purifying, laxative, appetizing, and cleansing effects on the gastrointestinal tract. Today, in basic and clinical studies on plants of the genus fumaria, the hepatoprotective effect, reducing effects of liver enzymes, anti-inflammatory effect in hepatic disorders, antidiarrheal effects, reducing effect of inflammatory factors in digestive disorders, and ameliorative effect on irritable bowel syndrome have been proven.
Conclusion: According to the Persian medicine literatures and modern medicine studies, Fumaria species can have therapeutic potential in some gastrointestinal and hepatic disorders.

کلیدواژه‌ها [English]

  • Fumaria officinalis
  • Fumitory
  • Gastrointestinal
  • Liver
  • Persian medicine
مراجع
  1. Ozaslan M. A comparison of Fumaria parviflora Lam. and Momordica balsamina Linn. hepatoprotection. Pak J Biol Sci. 2011;14(22):1034-5.
  2. Bribi N, Algieri F, Rodriguez-Nogales A, Vezza T, Garrido-Mesa J, Utrilla MP, et al. Intestinal anti-inflammatory effects of total alkaloid extract from Fumaria capreolata in the DNBS model of mice colitis and intestinal epithelial CMT93 cells. Phytomedicine. 2016;23(9):901-13.
  3. Khattak SG, Gilani SN, Ikram M. Antipyretic studies on some indigenous Pakistani medicinal plants. J Ethnopharmacol. 1985;14(1):45-51.
  4. Taleei GR, Meshkat Alsadat MH, Mousavi SZ. Antibacterial Activity Native Medicinal Plants Extracts In Lorestan, IRAN. Journal Of Gorgan University Of Medical Sciences. 2008;10(1 (25)):31-5. (Persian)
  5. Boadu AA, Asase A. Documentation of Herbal Medicines Used for the Treatment and Management of Human Diseases by Some Communities in Southern Ghana. Evid Based Complement Alternat Med. 2017;2017:3043061-.
  6. Regional Committee for A. Enhancing the role of traditional medicine in health systems: a strategy for the African Region. Brazzaville: WHO. Regional Office for Africa; 2013.
  7. Heshmati GA. Vegetation characteristics of four ecological zones of Iran. International Journal of Plant Production. 2012;1(2):215-24. (Persian)
  8. Derakhshan A, Khodadoost M, Ghanei M, Dehghan S, editors. The Link Between Allergic Rhinitis And Rheumatic Disorders: From Avicenna S View To Recent Findings2017. (Persian)
  9. Hentschel C, Dressler S, Hahn EG. [Fumaria officinalis (fumitory)--clinical applications]. Fortschr Med. 1995;113(19):291-2.
  10. Gupta PC, Sharma N, Rao CV. A review on ethnobotany, phytochemistry and pharmacology of Fumaria indica (Fumitory). Asian Pacific Journal of Tropical Biomedicine. 2012;2(8):665-9.
  11. Zhang R, Guo Q, Kennelly EJ, Long C, Chai X. Diverse alkaloids and biological activities of Fumaria (Papaveraceae): An ethnomedicinal group. Fitoterapia. 2020;146:104697.
  12. Singh GK, Chauhan SK, Rai G, Chatterjee SS, Kumar V. Potential antianxiety activity of Fumaria indica: A preclinical study. Pharmacogn Mag. 2013;9(33):14-22.
  13. Rezaeikia Z, Saeidi Sar S, Malakijoo N. Chemoprotective effect of Fumaria parviflora L. extract against vincristine induced hepatotoxicity in male rats. MEDICAL SCIENCES JOURNAL OF ISLAMIC AZAD UNIVERSITY. 2019;29(2 #R00655):125-30. (Persian)
  14. Fatemeh T, Mehdi A, Fatemeh N, Zahra K, Mohsen K. The effect of hydro-alcoholic extract of fumaria officinalis leaf on pain and seizure by pentylentetrazole-induced mice. Daneshvar Medicine. 2021;29(153):31-41. (Persian)
  15. Al-Ghazzawi AM, Abu Zarga MH, Abdalla SS. Chemical constituents of Fumaria densiflora and the effects of some isolated spirobenzylisoquinoline alkaloids on murine isolated ileum and perfused heart. Nat Prod Res. 2020;34(8):1180-5.
  16. Rathi A, Srivastava AK, Shirwaikar A, Rawat AKS, Mehrotra S. Hepatoprotective potential of Fumaria indica Pugsley whole plant extracts, fractions and an isolated alkaloid protopine. Phytomedicine. 2008;15(6-7):470-7.
  17. Abuzinadah MF, Ahmad A. Pharmacological studies on the efficacy of a thymoquinone-containing novel polyherbal formulation against cisplatin-induced hepatorenal toxicity in rats. J Food Biochem. 2020;44(2):e13131.
  18. Ried K, Travica N, Dorairaj R, Sali A. Herbal formula improves upper and lower gastrointestinal symptoms and gut health in Australian adults with digestive disorders. Nutr Res. 2020;76:37-51.
  19. Saha L. Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine. World J Gastroenterol. 2014;20(22):6759-73.
  20. Rezaeizadeh H, Alizadeh M, Naseri M, Shams Ardakani MR (2009). The Traditional Iranian Medicine Point of View on Health and Disease. Iranian J Publ Health, 38(Suppl.1):169-172. (Persian)
  21. Herbal Medicines: PDR for Herbal Medicines. JAMA. 1999;281(19):1853-4.
  22. Souri M, Heydari Nasrabadi M, Shiravi AAH, Habibi Z. Interaction Between Fumari Parviflura Aqueous Extract And Cholorambocil On Spermatogenesis In Rats. Journal Of Animal Biology. 2009;2(1):11-8. (Persian)
  23. Derakhshan AR, Choopani R, Dehghan S. A new look at epicardial adipose tissue from the perspective of Iranian traditional medicine. Journal of integrative medicine. 2014;12(6):529-30. (Persian)
  24. Shakya A, Chatterjee SS, Kumar V. Holistic Psychopharmacology of <i>Fumaria indica</i> (Fumitory). Chinese Medicine. 2012;03No.04:18.
  25. Rao KS, Mishra S. Hepatoprotective activity of the whole plants of Fumaria indica. Indian journal of pharmaceutical sciences. 1997;59(4):165.
  26. Rathi A, Srivastava AK, Shirwaikar A, Singh Rawat AK, Mehrotra S. Hepatoprotective potential of Fumaria indica Pugsley whole plant extracts, fractions and an isolated alkaloid protopine. Phytomedicine. 2008;15(6-7):470-7.
  27. Brice Landry K, Tariq S, Malik A, Sufyan M, Ashfaq UA, Ijaz B, et al. Berberis lyceum and Fumaria indica: in vitro cytotoxicity, antioxidant activity, and in silico screening of their selected phytochemicals as novel hepatitis C virus nonstructural protein 5A inhibitors. J Biomol Struct Dyn. 2021:1-25.
  28. Aoiadni N, Ayadi H, Jdidi H, Naifar M, Maalej S, Makni FA, et Flavonoid-rich fraction attenuates permethrin-induced toxicity by modulating ROS-mediated hepatic oxidative stress and mitochondrial dysfunction ex vivo and in vivo in rat. Environ Sci Pollut Res Int. 2021;28(8):9290-312.
  29. Arbab AH, Parvez MK, Al-Dosari MS, Al-Rehaily AJ. In vitro evaluation of novel antiviral activities of 60 medicinal plants extracts against hepatitis B virus. Exp Ther Med. 2017;14(1):626-34.
  30. Orhan IE, Şener B, Musharraf SG. Antioxidant and hepatoprotective activity appraisal of four selected Fumaria species and their total phenol and flavonoid quantities. Exp Toxicol Pathol. 2012;64(3):205-9.
  31. Abenavoli L, Greco M, Milic N, Accattato F, Foti D, Gulletta E, et al. Effect of Mediterranean diet and antioxidant formulation in non-alcoholic fatty liver disease: a randomized study. Nutrients. 2017;9(8):870.
  32. Hussain T, Siddiqui HH, Fareed S, Vijayakumar M, Rao CV. Evaluation of chemopreventive effect of Fumaria indica against N-nitrosodiethylamine and CCl4-induced hepatocellular carcinoma in Wistar rats. Asian Pacific Journal of Tropical Medicine. 2012;5(8):623-9.
  33. Brinkhaus B, Hentschel C, Von Keudell C, Schindler G, Lindner M, Stützer H, et al. Herbal medicine with curcuma and fumitory in the treatment of irritable bowel syndrome: a randomized, placebo-controlled, double-blind clinical trial. Scand J Gastroenterol. 2005;40(8):936-43.
  34. Bribi N, Rodríguez-Nogales A, Vezza T, Algieri F, Rodriguez-Cabezas ME, Garrido-Mesa J, et al. Intestinal anti-inflammatory activity of the total alkaloid fraction from Fumaria capreolata in the DSS model of colitis in mice. Bioorg Med Chem Lett. 2020;30(18):127414.
  35. Najeeb ur R, Bashir S, Al-Rehaily AJ, Gilani AH. Mechanisms underlying the antidiarrheal, antispasmodic and bronchodilator activities of Fumaria parviflora and involvement of tissue and species specificity. J Ethnopharmacol. 2012;144(1):128-37.
  36. Gilani AH, Bashir S, Janbaz KH, Khan A. Pharmacological basis for the use of Fumaria indica in constipation and diarrhea. Journal of Ethnopharmacology. 2005;96(3):585-9. (Persian)
  37. Mandal U, De D, Ali KM, Biswas A, Ghosh D. Effect of different solvent extracts of Benincasa hispida T. on experimental hypochlorhydria in rat. Journal of Advanced Pharmaceutical Technology & Research. 2012;3(1):41.
  38. Mandal U, Ali KM, Chatterjee K, De D, Biswas A, Ghosh D. Management of experimental hypochlorhydria with iron deficiency by the composite extract of Fumaria vaillantii L. and Benincasa hispida T. in rat. J Nat Sci Biol Med. 2014;5(2):397-4
  39. Montaseri S, Pourarian S, Montaseri H. Effects of Fumaria Extract on Colic Pain in 3-16 Weeks Infants. Iranian Journal of Neonatology IJN. 2013;4(2):10-5. (Persian)
  40. Rao CV, Verma AR, Gupta PK, MADHAVAN V. Anti-inflammatory and anti-nociceptive activities of Fumaria indica whole plant extract in experimental animals. Acta Pharmaceutica. 2007;57(4):491-8.
  41. The Canon of Medicine (Al-Qanon fi al-Tibb). al-Din IS (editor). Lebanon: Alamy Le- Al-Matbooat institute; 2005. [in Arabic].
  42. H K. Choleretsche Wirkung und Vertraeglichkeit von Chol-Kugeletten® bei Cholezystopathien. Therapiewoche. 1979;29:5645-55.
  43. R. Le nebulisat de fumeterre dans la régulation des troubles de intestinaux chroniques d’origine biliaire. Gazette Médicale de France. 1977;84:3794-8.
  44. Moin M. Farhang-e Fārsī. Vol. 2. Tehran: Amirkabir; 1992. (Persian)
  45. Elgood S. A Medical History of Persia and the Eastern Caliphate. Translated by Forghani B. Tehran: Amirkabir; 1992. [in Persian].
  46. Bonnet D, Mejdoubi S, Sommet A, Alric L. [Acute hepatitis probably induced by Fumaria and Vitis vinifera tinctoria herbal products]. Gastroenterol Clin Biol. 2007;31(11):1041-2.
  47. Zacharewicz M, Chorazy W, Mossor S, Zacharewicz M, Jr. [Treatment of cholecystopathies by Fumaria nebulisate]. Wien Med Wochenschr. 1979;129(8):221-4.
  48. Khan AY, Suresh Kumar G. Natural isoquinoline alkaloids: binding aspects to functional proteins, serum albumins, hemoglobin, and lysozyme. Biophys Rev. 2015;7(4):407-20.
  49. Shen Y, Song X, Li L, Sun J, Jaiswal Y, Huang J, et al. Protective effects of p-coumaric acid against oxidant and hyperlipidemia-an in vitro and in vivo evaluation. Biomedicine & Pharmacotherapy. 2019;111:579-87.
  50. Ganeshpurkar A, Saluja AK. The Pharmacological Potential of Saudi Pharmaceutical Journal. 2017;25(2):149-64.
  51. Sova M, Saso L. Natural Sources, Pharmacokinetics, Biological Activities and Health Benefits of Hydroxycinnamic Acids and Their Metabolites. Nutrients. 2020;12(8):2190.
  52. El-Seedi HR, El-Said AM, Khalifa SA, Göransson U, Bohlin L, Borg-Karlson AK, et al. Biosynthesis, natural sources, dietary intake, pharmacokinetic properties, and biological activities of hydroxycinnamic acids. J Agric Food Chem. 2012;60(44):10877-95.
  53. Šilhavý J, Zídek V, Mlejnek P, Landa V, Šimáková M, Strnad H, et al. Fumaric acid esters can block pro-inflammatory actions of human CRP and ameliorate metabolic disturbances in transgenic spontaneously hypertensive rats. PLoS One. 2014;9(7):e101906-e.
  54. Derakhshan AR. Natural Treatments for Fissure in Ano Used by Traditional Persian Scholars, Razi (Rhazes) and Ibn Sina (Avicenna). Journal of evidence-based complementary & alternative medicine. 2017;22(2):324-33. (Persian) 
مجله دانشگاه علوم پزشکی سبزوار
دوره 29، شماره 5
آذر و دی 1401
صفحه 697-718
فایل ها
سابقه مقاله
  • تاریخ دریافت: 10 فروردین 1401
  • تاریخ بازنگری: 17 خرداد 1401
  • تاریخ پذیرش: 18 خرداد 1401
هم رسانی
ارجاع به این مقاله
آمار